Reuters reports that WellPoint is under federal investigation for singling out breast cancer patients and dropping their coverage “based on either erroneous or flimsy information.”  They also report that language in the House bill would have protected these women, but it was removed in the Senate version of the bill because “lobbyists for WellPoint and [...]